A phase IIII, randomised, observer blind, placebo controlled, multi centre, clinical trial to assess the prophylactic efficacy, safety, and immunogenicity of GSK Biologicals' herpes Zoster gE/AS01

  • Schwarer, Anthony (Primary Chief Investigator (PCI))

Project: Research

Project Details

StatusFinished
Effective start/end date1/11/12 → 1/03/14